Yonhap Infomax NewsSamsung Biologics Co. secures a $1.3 billion CMO contract with a US pharmaceutical firm, pushing its 2025 order intake past 5 trillion won and reinforcing its global leadership in biomanufacturing capacity.
#YonhapInfomax #SamsungBiologics #CMOContract #OrderIntake #Biomanufacturing #USPharmaceuticalCompany #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=80780
#YonhapInfomax #SamsungBiologics #CMOContract #OrderIntake #Biomanufacturing #USPharmaceuticalCompany #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=80780
Samsung Biologics Signs $1.3 Billion CMO Deal With US Pharma Firm, Annual Orders Surpass 5 Trillion Won
Samsung Biologics Co. secures a $1.3 billion CMO contract with a US pharmaceutical firm, pushing its 2025 order intake past 5 trillion won and reinforcing its global leadership in biomanufacturing capacity.